1. Home
  2. ATS vs ADPT Comparison

ATS vs ADPT Comparison

Compare ATS & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ATS Corporation

ATS

ATS Corporation

HOLD

Current Price

$28.02

Market Cap

2.9B

Sector

N/A

ML Signal

HOLD

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

HOLD

Current Price

$12.85

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATS
ADPT
Founded
1978
2009
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.5B
IPO Year
2007
2019

Fundamental Metrics

Financial Performance
Metric
ATS
ADPT
Price
$28.02
$12.85
Analyst Decision
Hold
Strong Buy
Analyst Count
1
9
Target Price
$35.00
$17.78
AVG Volume (30 Days)
144.7K
1.7M
Earning Date
01-01-0001
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
63.89
EPS
N/A
N/A
Revenue
N/A
$276,976,000.00
Revenue This Year
$17.99
$3.98
Revenue Next Year
$3.91
$22.72
P/E Ratio
$222.92
N/A
Revenue Growth
N/A
54.77
52 Week Low
$20.90
$6.68
52 Week High
$33.01
$20.76

Technical Indicators

Market Signals
Indicator
ATS
ADPT
Relative Strength Index (RSI) 32.23 28.24
Support Level $26.12 $12.32
Resistance Level $28.19 $13.45
Average True Range (ATR) 1.03 0.82
MACD -0.56 -0.30
Stochastic Oscillator 0.00 16.57

Price Performance

Historical Comparison
ATS
ADPT

About ATS ATS Corporation

ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails, tray handlers, laser systems, and other hardware and software products. The company also provides pre-automation solutions, including strategic direction and planning services, as well as aftermarket support. The company's clients come from the life sciences, food and beverage transportation, consumer products and electronics, and energy sectors. The company generates the majority of its sales from the North American and European markets.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: